杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/15 | 1,681 | 1,691 | 1,676 | 1,676 | -7 | -0.4% | 77,700 |
| 2022/06/14 | 1,698 | 1,699 | 1,681 | 1,683 | -18 | -1.1% | 64,100 |
| 2022/06/13 | 1,686 | 1,708 | 1,685 | 1,701 | +15 | +0.9% | 73,400 |
| 2022/06/10 | 1,688 | 1,695 | 1,681 | 1,686 | -14 | -0.8% | 96,600 |
| 2022/06/09 | 1,710 | 1,718 | 1,697 | 1,700 | -15 | -0.9% | 91,400 |
| 2022/06/08 | 1,702 | 1,723 | 1,702 | 1,715 | +17 | +1% | 62,700 |
| 2022/06/07 | 1,691 | 1,705 | 1,686 | 1,698 | +11 | +0.7% | 54,000 |
| 2022/06/06 | 1,682 | 1,698 | 1,681 | 1,687 | +2 | +0.1% | 44,700 |
| 2022/06/03 | 1,701 | 1,708 | 1,684 | 1,685 | -13 | -0.8% | 80,600 |
| 2022/06/02 | 1,686 | 1,701 | 1,673 | 1,698 | +3 | +0.2% | 86,400 |
| 2022/06/01 | 1,673 | 1,702 | 1,673 | 1,695 | +32 | +1.9% | 84,900 |
| 2022/05/31 | 1,685 | 1,697 | 1,662 | 1,663 | -34 | -2% | 285,500 |
| 2022/05/30 | 1,687 | 1,705 | 1,677 | 1,697 | +20 | +1.2% | 142,100 |
| 2022/05/27 | 1,678 | 1,685 | 1,658 | 1,677 | -1 | -0.1% | 76,700 |
| 2022/05/26 | 1,670 | 1,692 | 1,670 | 1,678 | +3 | +0.2% | 65,800 |
| 2022/05/25 | 1,704 | 1,709 | 1,675 | 1,675 | -24 | -1.4% | 107,500 |
| 2022/05/24 | 1,700 | 1,710 | 1,691 | 1,699 | -24 | -1.4% | 73,300 |
| 2022/05/23 | 1,705 | 1,733 | 1,705 | 1,723 | +31 | +1.8% | 60,900 |
| 2022/05/20 | 1,710 | 1,711 | 1,686 | 1,692 | -17 | -1% | 89,400 |
| 2022/05/19 | 1,690 | 1,713 | 1,686 | 1,709 | -2 | -0.1% | 72,500 |
| 2022/05/18 | 1,697 | 1,714 | 1,692 | 1,711 | +8 | +0.5% | 60,100 |
| 2022/05/17 | 1,692 | 1,722 | 1,692 | 1,703 | +14 | +0.8% | 59,200 |
| 2022/05/16 | 1,741 | 1,755 | 1,685 | 1,689 | -41 | -2.4% | 129,400 |
| 2022/05/13 | 1,730 | 1,740 | 1,696 | 1,730 | -3 | -0.2% | 102,400 |
| 2022/05/12 | 1,821 | 1,821 | 1,733 | 1,733 | -88 | -4.8% | 108,300 |
| 2022/05/11 | 1,849 | 1,852 | 1,812 | 1,821 | -36 | -1.9% | 65,800 |
| 2022/05/10 | 1,859 | 1,867 | 1,835 | 1,857 | -10 | -0.5% | 88,200 |
| 2022/05/09 | 1,890 | 1,898 | 1,859 | 1,867 | -24 | -1.3% | 88,000 |
| 2022/05/06 | 1,896 | 1,898 | 1,876 | 1,891 | -14 | -0.7% | 78,100 |
| 2022/05/02 | 1,883 | 1,910 | 1,877 | 1,905 | +14 | +0.7% | 85,000 |
| 2022/04/28 | 1,821 | 1,897 | 1,819 | 1,891 | +70 | +3.8% | 184,500 |
| 2022/04/27 | 1,830 | 1,855 | 1,801 | 1,821 | -14 | -0.8% | 166,000 |
| 2022/04/26 | 1,815 | 1,852 | 1,815 | 1,835 | +20 | +1.1% | 120,600 |
| 2022/04/25 | 1,798 | 1,823 | 1,791 | 1,815 | +20 | +1.1% | 99,100 |
| 2022/04/22 | 1,776 | 1,797 | 1,767 | 1,795 | +3 | +0.2% | 34,300 |
| 2022/04/21 | 1,790 | 1,798 | 1,786 | 1,792 | +22 | +1.2% | 39,100 |
| 2022/04/20 | 1,769 | 1,781 | 1,758 | 1,770 | +10 | +0.6% | 49,300 |
| 2022/04/19 | 1,759 | 1,770 | 1,749 | 1,760 | -7 | -0.4% | 38,500 |
| 2022/04/18 | 1,780 | 1,780 | 1,741 | 1,767 | -27 | -1.5% | 62,900 |
| 2022/04/15 | 1,791 | 1,801 | 1,785 | 1,794 | -7 | -0.4% | 35,000 |
| 2022/04/14 | 1,808 | 1,817 | 1,794 | 1,801 | -14 | -0.8% | 39,200 |
| 2022/04/13 | 1,796 | 1,815 | 1,789 | 1,815 | +19 | +1.1% | 61,300 |
| 2022/04/12 | 1,806 | 1,808 | 1,792 | 1,796 | -16 | -0.9% | 43,700 |
| 2022/04/11 | 1,814 | 1,820 | 1,801 | 1,812 | -3 | -0.2% | 70,600 |
| 2022/04/08 | 1,811 | 1,815 | 1,786 | 1,815 | +25 | +1.4% | 95,800 |
| 2022/04/07 | 1,775 | 1,792 | 1,770 | 1,790 | +8 | +0.4% | 48,600 |
| 2022/04/06 | 1,814 | 1,817 | 1,778 | 1,782 | -31 | -1.7% | 47,200 |
| 2022/04/05 | 1,820 | 1,821 | 1,802 | 1,813 | +11 | +0.6% | 66,000 |
| 2022/04/04 | 1,786 | 1,809 | 1,786 | 1,802 | +16 | +0.9% | 35,800 |
| 2022/04/01 | 1,769 | 1,799 | 1,766 | 1,786 | +9 | +0.5% | 60,900 |
601～
650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
